The lack of association between MASLD and tobacco use or hypothyroidism in the (MHO+) group is noteworthy when compared with some previous studies in other populations [[18], [19], [20]], [[18], [19], [20]], [20,21].Regarding hypothyroidism, the regular use of thyroid hormone replacement therapy in diagnosed patients may help regulate metabolic processes, potentially reducing MASLD risk [22]. Here, TG is linked to hypothyroidism.